Response to letter Re: Response to checkpoint inhibition and targeted therapy in melanoma patients with concurrent haematological malignancies

Olivier J van Not; Willeke A M Blokx; Michel W J M Wouters; Karijn P M Suijkerbuijk

doi:10.1016/j.ejca.2023.112983

Response to letter Re: Response to checkpoint inhibition and targeted therapy in melanoma patients with concurrent haematological malignancies

Olivier J van Not, Willeke A M Blokx, Michel W J M Wouters, Karijn P M Suijkerbuijk

Research output: Contribution to journal › Letter › Academic › peer-review

Original language	English
Article number	112983
Pages (from-to)	112983
Number of pages	1
Journal	European Journal of Cancer
Volume	191
Early online date	1 Aug 2023
DOIs	https://doi.org/10.1016/j.ejca.2023.112983
Publication status	Published - 1 Sept 2023

Access to Document

10.1016/j.ejca.2023.112983

Cite this

@article{794ac385891f4ddb9232fc0f3197c09d,

title = "Response to letter Re: Response to checkpoint inhibition and targeted therapy in melanoma patients with concurrent haematological malignancies",

author = "{van Not}, {Olivier J} and Blokx, {Willeke A M} and Wouters, {Michel W J M} and Suijkerbuijk, {Karijn P M}",

year = "2023",

month = sep,

day = "1",

doi = "10.1016/j.ejca.2023.112983",

language = "English",

volume = "191",

pages = "112983",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Response to letter Re

T2 - Response to checkpoint inhibition and targeted therapy in melanoma patients with concurrent haematological malignancies

AU - van Not, Olivier J

AU - Blokx, Willeke A M

AU - Wouters, Michel W J M

AU - Suijkerbuijk, Karijn P M

PY - 2023/9/1

Y1 - 2023/9/1

UR - http://www.scopus.com/inward/record.url?scp=85168810044&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2023.112983

DO - 10.1016/j.ejca.2023.112983

M3 - Letter

C2 - 37537090

SN - 0959-8049

VL - 191

SP - 112983

JO - European Journal of Cancer

JF - European Journal of Cancer

M1 - 112983

ER -

Response to letter Re: Response to checkpoint inhibition and targeted therapy in melanoma patients with concurrent haematological malignancies

Access to Document

Other files and links

Cite this